Scenarios that move OCUL
Ocular Therapeutix, Inc. - Common Stock
Scenarios that move OCUL: 3 analyses, 1 positive, 2 negative.
- · Opus Genetics receives FDA approval for presbyopia eye drop — ▲ · impact +45 · confidence low · horizon weeks
- · Roche reports positive Phase III eye drug data, FDA accepts BLA — ▼ · impact -38 · confidence low · horizon weeks
- · Kodiak Sciences shares soar 178% on positive wet AMD data — ▼ · impact -52 · confidence low · horizon immediate